Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for noninfectious diarrhea experienced by adults with HIV/AIDS undergoing antiretroviral therapy. Beyond its commercial product, Jaguar Health is actively advancing Crofelemer, the active pharmaceutical ingredient in Mytesi, for a broad spectrum of additional indications. These include managing diarrhea associated with cancer therapy, seeking orphan drug designation for symptomatic relief in infants and children with congenital diarrheal disorders, and for adult and pediatric patients suffering from short bowel syndrome with intestinal failure. Further potential applications encompass supportive care for diarrhea linked to inflammatory bowel diseases, diarrhea-predominant irritable bowel syndrome (IBS-D), and idiopathic or functional diarrhea. Their pipeline also features lechlemer, a next-generation anti-secretory agent being developed to combat cholera. In the animal health sector, they are developing Canalevia, an oral, plant-derived drug candidate designed to address chemotherapy-induced diarrhea and exercise-induced diarrhea in canines. Established in 2013, Jaguar Health, Inc. maintains its headquarters in San Francisco, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Jaguar Health, Inc.
No short interest data available.
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:15Reverse splitSep 17, 202615 shares → 1
- 1:35Reverse splitApr 30, 202635 shares → 1
- 1:25Reverse splitMar 24, 202525 shares → 1
- 1:60Reverse splitMay 23, 202460 shares → 1
- 1:75Reverse splitJan 23, 202375 shares → 1
- 1:3Reverse splitSep 8, 20213 shares → 1
- 1:70Reverse splitJun 7, 201970 shares → 1
- 1:15Reverse splitJun 1, 201815 shares → 1
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $11.51M | $11.69M | $9.76M | $11.96M | $4.33M | $9.38M | $5.78M | $4.42M | $4.36M | $142K | $258K | $0 |
| YoY Growth | -1.5% | 19.8% | -18.4% | 175.8% | -53.8% | 62.5% | 30.8% | 1.3% | 2981.6% | -45.2% | - | - |
| Cost of Revenue | $3.77M | $1.96M | $2.04M | $2.02M | $2.33M | $3.28M | $3.82M | $2.77M | $880K | $52K | $123K | $0 |
| Gross Profit | $7.74M | $9.73M | $7.72M | $9.94M | $2M | $6.11M | $1.96M | $1.65M | $3.48M | $90K | $135K | $0 |
| Gross Margin | 67.2% | 83.3% | 79.1% | 83.1% | 46.2% | 65.1% | 33.9% | 37.4% | 79.8% | 63.3% | 52.2% | - |
| Research and Development | $24.97M | $16.54M | $18.6M | $17.65M | $15.08M | $6.41M | $5.82M | $5.15M | $4.27M | $7.21M | $6.48M | $4.22M |
| Selling, General, and Administrative | $26.02M | $24.02M | $23.05M | $26.7M | $26M | $21M | $20.44M | $22.11M | $14.33M | $6.47M | $6.1M | $4.1M |
| Other | $1.86M | $0 | $371K | $0 | $1.63M | $5.34M | $4.65M | $0 | $89K | -$11K | -$27K | $0 |
| Total Operating Expenses | $52.84M | $40.56M | $42.02M | $44.35M | $42.71M | $32.75M | $30.91M | $27.26M | $18.6M | $13.68M | $12.58M | $8.32M |
| Operating Income (EBIT) | -$45.11M | -$30.83M | -$34.29M | -$34.41M | -$40.71M | -$26.65M | -$28.95M | -$30.82M | -$34.25M | -$13.59M | -$12.45M | -$8.32M |
| Operating Margin | -391.9% | -263.8% | -351.3% | -287.8% | -939.1% | -283.9% | -501.3% | -698.0% | -785.3% | -9599.8% | -4816.7% | - |
| Interest Expense | -$67K | $231K | $6.38M | $12.72M | $8.42M | $2.79M | $5.73M | $2.63M | $1.21M | $986K | $3.32M | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $2.79M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$8.89M | -$8.42M | -$7.61M | -$13.98M | -$11.89M | -$7.16M | -$9.58M | -$1.32M | -$903K | -$1.15M | -$3.85M | -$294K |
| Income Before Tax (EBT) | -$54M | -$39.25M | -$41.9M | -$48.4M | -$52.6M | -$33.81M | -$38.53M | -$32.15M | -$35.15M | -$14.73M | -$16.29M | -$8.61M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $10K | $0 | -$13.18M | $0 | $0 | $0 |
| Net Income | -$53.43M | -$38.49M | -$41.3M | -$47.45M | -$52.59M | -$33.81M | -$38.54M | -$32.15M | -$21.97M | -$14.73M | -$16.29M | -$8.61M |
| Net Income Margin | -464.2% | -329.3% | -423.1% | -396.9% | -1213.3% | -360.2% | -667.3% | -727.9% | -503.7% | -10410.9% | -6305.2% | - |
| Supplementary Data | ||||||||||||
| EPS | -12059.25 | -68611.05 | -1409880.00 | -28492920.00 | -69476385.00 | -177212295.00 | -1596051840.00 | -27158254770.00 | -94883906280.00 | -251163281340.00 | -502326562680.00 | -375814687635.00 |
| Diluted EPS | -12059.25 | -68611.05 | -1409880.00 | -28492920.00 | -69476385.00 | -177212295.00 | -1596051840.00 | -27158254770.00 | -94883906280.00 | -251163281340.00 | -502326562680.00 | -375814687635.00 |
| Weighted Average OS | 4,443 | 561 | 29 | 1.665 | 0.757 | 0.218 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -$51.73M | -$36.66M | -$31.53M | -$33.38M | -$42.37M | -$28.74M | -$30.87M | -$28.2M | -$11.13M | -$13.7M | -$12.97M | -$8.26M |
| EBITDA Margin | -449.4% | -313.6% | -323.0% | -279.2% | -977.3% | -306.2% | -534.5% | -638.5% | -255.2% | -9680.9% | -5019.4% | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $968K | $8M | $6.47M | $5.47M | $17.05M | $8.09M | $3.5M | $2.57M | $521K | $951K | $7.7M | $2.1M | $185K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $968K | $8M | $6.47M | $5.47M | $17.05M | $8.09M | $3.5M | $2.57M | $521K | $951K | $7.7M | $2.1M | $185K |
| Accounts Receivable | $1.7M | $1.65M | $2.18M | $2.47M | $2.14M | $4.56M | $1.69M | $1M | $469K | $305K | $59K | $1.25M | $0 |
| Inventory | $8.6M | $10.35M | $9.19M | $7.02M | $4.9M | $2.78M | $2.13M | $3.34M | $2.07M | $413K | $230K | $198K | $0 |
| Other Current Assets | $9.08M | $12.2M | $10.12M | $7.36M | $0 | $0 | $941K | $6K | $239K | $584K | $143K | $2.57M | $4K |
| Total Current Assets | $20.34M | $32.2M | $27.96M | $22.32M | $28.43M | $17.79M | $9.52M | $8.15M | $3.8M | $2.56M | $8.45M | $4.88M | $289K |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $1.46M | $1.4M | $1.67M | $1.7M | $1.73M | $677K | $710K | $761K | $1.22M | $886K | $829K | $873K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.21M | $0 | $0 | $0 | $0 |
| Intangible Assets | $16.02M | $18.48M | $20.12M | $22.44M | $22.65M | $24.34M | $26.02M | $31.71M | $33.4M | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $494K | $1.35M | $1.01M | $995K | $446K | $37K | $154K | $421K | $0 | $122K | $122K | $0 | $0 |
| Total Long-Term Assets | $17.98M | $21.23M | $22.8M | $25.13M | $24.83M | $25.05M | $26.89M | $32.89M | $39.83M | $1.01M | $3.95M | $873K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $38.32M | $53.42M | $50.76M | $47.45M | $53.27M | $42.84M | $36.41M | $41.04M | $43.63M | $3.56M | $12.41M | $5.76M | $289K |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $8.69M | $5.29M | $4.97M | $5.81M | $4.93M | $4.76M | $5.35M | $5.41M | $7.35M | $517K | $574K | $698K | $9K |
| Short-Term Debt | $27.44M | $12.04M | $4.87M | $15.88M | $3.18M | $3.79M | $6.78M | $16.08M | $5.42M | $2.07M | $1.86M | $817K | $519K |
| Current Income Tax Payable | $0 | $114K | $292K | $585K | $510K | $127K | $241K | $153K | $71K | $20K | $44K | $0 | $0 |
| Current Unearned Revenue | $170K | $170K | $0 | $0 | $0 | $0 | $0 | $4.94M | $177K | $224K | $252K | $24K | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $1K | $179K | $3K | $374K | $2.17M | $1.16M | $469K | -$88K | $116K |
| Total Current Liabilities | $40.65M | $19.7M | $13.99M | $30.34M | $15.47M | $13.22M | $15.39M | $26.66M | $15.39M | $4.19M | $3.91M | $2.79M | $724K |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $15.08M | $23.5M | $30.99M | $17.74M | $25.02M | $12.42M | $450K | $0 | $10.98M | $1.82M | $4.1M | $0 | $0 |
| Long-Term Unearned Revenue | $382K | $553K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3K | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3K | $0 | $0 |
| Other Long-Term Liabilities | $0 | $2.48M | $0 | $0 | $0 | $0 | $9.89M | $0 | $0 | $7K | $3K | $1.88M | $0 |
| Total Long-Term Liabilities | $16.36M | $27.23M | $31.88M | $18.47M | $25.94M | $12.42M | $10.35M | $9M | $10.98M | $1.82M | $4.1M | $1.88M | $528K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$528K |
| Total Liabilities | $57.01M | $46.93M | $45.87M | $48.81M | $41.41M | $25.64M | $25.74M | $35.66M | $26.37M | $6.02M | $8.01M | $4.66M | $724K |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $2.48M | $0 | $0 | $0 | $0 | $0 | $1.71M | $9T | $43.63T | $3.56T | $12.41B | $0 | $0 |
| Common Stock | $1K | $0 | $0 | $0 | $5K | $4K | $5K | $6K | $11K | $1K | $812 | $525 | $267 |
| Retained Earnings | -$399.92M | -$346.48M | -$308.25M | -$266.95M | -$219.49M | -$166.9M | -$133.09M | -$94.55M | -$62.4M | -$40.44M | -$25.7M | -$11.09M | -$801K |
| Comprehensive Income & Other | -$833K | -$467K | -$652K | -$680K | $0 | $0 | $0 | -$9T | -$43.63T | -$3.56T | -$12.41B | $0 | $0 |
| Other Stockholders' Equity | $382.63M | $353.77M | $313.21M | $266.29M | $231.1M | $184.1M | $143.76M | $99.93M | $79.66M | $37.98M | $30.1M | $12.18M | $366K |
| Total Equity | -$17.29M | $7.29M | $4.96M | -$657K | $11.61M | $17.2M | $10.67M | $5.38M | $17.26M | -$2.45M | $4.4M | $1.1M | -$435K |
| Minority Interest | -$1.4M | -$791K | -$64K | -$699K | $242K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $39.72M | $54.22M | $50.83M | $48.15M | $53.02M | $42.84M | $36.41M | $41.04M | $43.63M | $3.56M | $12.41M | $5.76M | $289K |
| Supplementary Data | |||||||||||||
| Total Debt | $43.61M | $36.53M | $37.09M | $34.84M | $29.36M | $16.21M | $7.57M | $16.08M | $16.41M | $3.89M | $5.95M | $729K | $519K |
| Net Debt | $42.64M | $28.52M | $30.63M | $29.37M | $12.31M | $8.12M | $4.07M | $13.52M | $15.88M | $2.94M | -$1.74M | -$1.37M | $334K |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$15.37M | -$39.03M | -$41.87M | -$49.08M | -$52.6M | -$33.81M | -$38.54M | -$32.15M | -$21.97M | -$14.73M | -$16.29M | -$8.61M |
| Depreciation & Amortization | $2.2M | $2.36M | $2.39M | $2.29M | $1.81M | $2.28M | $1.93M | $1.32M | $584K | $47K | $5K | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $4.39M | $0 | $0 | $5.75M | -$13.18M | $151K | $536K | $0 |
| Stock-Based Compensation | -$810K | $1.64M | $2.11M | $3.32M | $3.97M | $2.82M | $2.99M | $2.02M | $815K | $718K | $992K | $164K |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | -$434K | $526K | $298K | -$170K | $2.82M | -$2.87M | -$704K | -$528K | -$166K | $51K | -$56K | $1.09M |
| Inventory | $902K | -$1.16M | -$2.17M | -$2.12M | -$2.12M | -$653K | $1.21M | -$1.27M | $128K | -$183K | -$32K | -$198K |
| Accounts Payable | $3.02M | $328K | -$855K | $902K | $158K | -$743K | -$63K | -$1.94M | $4.19M | -$28K | -$240K | $689K |
| Other Working Capital | $9.4M | -$2.71M | -$8.38M | -$3.04M | $1.4M | $795K | -$1.11M | $2.81M | -$23K | -$986K | -$1.96M | $24K |
| Total Working Capital Change | $12.89M | -$3.01M | -$11.1M | -$4.43M | $2.27M | -$3.47M | -$662K | -$925K | $4.13M | -$1.15M | -$2.28M | $1.6M |
| Other Non-Cash Items | $6.89M | $8.66M | $15.23M | $14.79M | $5.19M | $16.89M | $13.83M | $1.25M | $19.8M | $549K | $2.73M | $1.38M |
| Net Cash from Operating | $5.8M | -$29.38M | -$33.24M | -$33.1M | -$34.97M | -$15.28M | -$20.46M | -$22.73M | -$9.82M | -$14.41M | -$14.32M | -$5.46M |
| Investing Activities | ||||||||||||
| Capital Expenditures | -$25K | -$16K | $0 | -$77K | -$6K | -$7K | $0 | -$7K | $0 | -$104K | -$23K | -$55K |
| Acquisitions | $0 | $0 | $0 | $0 | $247K | $0 | $0 | $0 | -$1.56M | $0 | $21K | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3M | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 |
| Other Investing Activities | $174K | -$215K | $0 | -$1.6M | -$247K | $0 | $0 | -$7K | $272K | $2.49M | -$2.98M | $0 |
| Net Cash from Investing | $149K | -$231K | $0 | -$1.68M | -$6K | -$7K | $0 | -$7K | -$1.29M | $2.38M | -$3M | -$55K |
| Financing Activities | ||||||||||||
| Debt Repaid | $20.91M | $100K | $100K | -$3.88M | -$9.05M | -$5.69M | $100K | -$876K | -$378K | $2.49M | -$4.52M | - |
| Common Stock Issuance | $1.86M | $31.91M | $32.1M | $20.46M | $33.58M | $1.95M | $6.63M | $16.68M | $10.3M | $8.83M | $18.81M | $0 |
| Common Stock Repurchases | -$31.07M | $0 | $0 | $0 | $0 | $0 | $0 | -$30 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$44K | -$608K | $1.62M | -$1.16M | $1.31M | $11.86M | $9.23M | -$2.12M | $0 | -$1.06M | -$405K | -$2.38M |
| Net Cash from Financing | -$44.33M | $31.2M | $34.23M | $23.18M | $43.94M | $19.49M | $21.77M | $24.55M | $10.68M | $5.28M | $24.17M | $6.18M |
| Forex Effect | -$59K | -$54K | $15K | $16K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$38.35M | $1.53M | $1M | -$11.58M | $8.96M | $4.21M | $1.31M | $1.81M | -$430K | -$6.75M | $6.85M | $660K |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | $5.8M | -$29.38M | -$33.24M | -$33.1M | -$34.97M | -$15.28M | -$20.46M | -$22.73M | -$9.82M | -$14.41M | -$14.32M | -$5.46M |
| Capital Expenditure | -$25K | -$231K | $0 | -$1.68M | -$6K | -$7K | $0 | -$7K | $0 | -$104K | -$23K | -$55K |
| Free Cash Flow | $5.77M | -$29.61M | -$33.24M | -$34.78M | -$34.98M | -$15.29M | -$20.46M | -$22.74M | -$9.82M | -$14.52M | -$14.34M | -$5.52M |
| Cash at Beginning | $46.19M | $6.47M | $5.47M | $17.05M | $8.09M | $3.88M | $2.57M | $760K | $951K | $7.7M | $845K | $185K |
| Cash at End | $7.83M | $8M | $6.47M | $5.47M | $17.05M | $8.09M | $3.88M | $2.57M | $521K | $951K | $7.7M | $845K |